301 related articles for article (PubMed ID: 22750230)
1. Mechanism of inhibition of lipopolysaccharide-induced interferon-β production by 2-aminopurine.
Sugiyama T; Gotou T; Moriyama K; Kajiura N; Hasegawa T; Tomida J; Takahashi K; Komatsu T; Ueda H; Sato K; Tokoro S; Neri P; Mori H
Mol Immunol; 2012 Oct; 52(3-4):299-304. PubMed ID: 22750230
[TBL] [Abstract][Full Text] [Related]
2. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
3. 2-aminopurine inhibits lipopolysaccharide-induced nitric oxide production by preventing IFN-beta production.
Sugiyama T; Fujita M; Koide N; Mori I; Yoshida T; Mori H; Yokochi T
Microbiol Immunol; 2004; 48(12):957-63. PubMed ID: 15611612
[TBL] [Abstract][Full Text] [Related]
4. Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4.
Lee JS; Lee JY; Lee MY; Hwang DH; Youn HS
Mol Cells; 2008 Apr; 25(2):253-7. PubMed ID: 18414004
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
Kadoki M; Choi BI; Iwakura Y
Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
[TBL] [Abstract][Full Text] [Related]
7. AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.
Zenke K; Muroi M; Tanamoto KI
Cell Signal; 2018 Mar; 43():32-39. PubMed ID: 29242168
[TBL] [Abstract][Full Text] [Related]
8. PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis.
Zhang J; Xu LG; Han KJ; Wei X; Shu HB
FEBS Lett; 2004 Jul; 570(1-3):97-101. PubMed ID: 15251447
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
[TBL] [Abstract][Full Text] [Related]
10. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
11. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects.
Kim MH; Yoo DS; Lee SY; Byeon SE; Lee YG; Min T; Rho HS; Rhee MH; Lee J; Cho JY
Pharmazie; 2011 Apr; 66(4):293-300. PubMed ID: 21612158
[TBL] [Abstract][Full Text] [Related]
12. Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma.
Gusella GL; Musso T; Rottschafer SE; Pulkki K; Varesio L
J Immunol; 1995 Jan; 154(1):345-54. PubMed ID: 7995954
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol inhibits lipopolysaccharide-induced TNF-α production through inactivation of nuclear factor-κB and mitogen-activated protein kinases in the MyD88-dependent pathway.
Haque A; Koide N; Iftakhar-E-Khuda I; Noman AS; Odkhuu E; Badamtseren B; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Microbiol Immunol; 2011 Mar; 55(3):160-7. PubMed ID: 21204955
[TBL] [Abstract][Full Text] [Related]
15. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
[TBL] [Abstract][Full Text] [Related]
16. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.
Schmitz F; Heit A; Guggemoos S; Krug A; Mages J; Schiemann M; Adler H; Drexler I; Haas T; Lang R; Wagner H
Eur J Immunol; 2007 Feb; 37(2):315-27. PubMed ID: 17273999
[TBL] [Abstract][Full Text] [Related]
17. Anesthetic agent propofol inhibits myeloid differentiation factor 88-dependent and independent signaling and mitigates lipopolysaccharide-mediated reactive oxygen species production in human neutrophils in vitro.
Ren X; Lv F; Fang B; Liu S; Lv H; He G; Ma H; Cao Y; Wang Y
Eur J Pharmacol; 2014 Dec; 744():164-72. PubMed ID: 25446563
[TBL] [Abstract][Full Text] [Related]
18. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
19. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
20. Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells.
Lee JH; Park EJ; Kim OS; Kim HY; Joe EH; Jou I
Glia; 2005 Apr; 50(1):66-79. PubMed ID: 15630703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
